Levocarnitine Tablet
Product Images NDC 16571-762

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocarnitine (NDC 16571-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocarnitine-carton-label (Levocarnitine Carton Label)

Packaging label for Levocarnitine Tablets, USP 330 mg oral tablets, labeled for prescription use only. The label shows the NDC 16571-762-09 and indicates 90 unit-dose tablets in the package. Manufactured by Graviti Pharmaceuticals Private Limited, India, and distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ. The label includes storage instructions and child safety warnings.*

FDA Label Image

Levocarnitine-struc (Levocarnitine Struc)

Chemical structure diagram of Levocarnitine, the active ingredient of Levocarnitine oral tablets. The structure shows the molecular arrangement including a positively charged nitrogen and carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.